Accendra Health INC/Va/ (ACH) — SEC Filings

Overview

Accendra Health INC/Va/ (ACH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Apr 2, 2026: Accendra Health Inc./VA/ filed its Annual Report to Security Holders (ARS) on April 2, 2026, for the period ending December 31, 2025. The filing, with SEC Accession No. 0001104659-26-038833, details the company's operations in wholesale medical, dental, and hospital equipment and supplies.

Sentiment Summary

Across 46 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 43 neutral. The dominant filing sentiment for Accendra Health INC/Va/ is neutral.

Filing Type Overview

Accendra Health INC/Va/ (ACH) has filed 1 ARS, 1 DEFA14A, 31 8-K, 5 10-Q, 1 10-K, 5 SC 13G/A, 1 DEF 14A, 1 SC 13G with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (46)

• Accendra Health Files 2025 Annual Report — ARS · Apr 2, 2026 Risk: low
  Accendra Health Inc./VA/ filed its Annual Report to Security Holders (ARS) on April 2, 2026, for the period ending December 31, 2025. The filing, with SEC Acces
• Accendra Health Files Additional Proxy Materials — DEFA14A · Apr 2, 2026 Risk: low
  Accendra Health Inc. filed a Definitive Additional Materials (DEFA14A) on April 2, 2026. The filing concerns additional definitive proxy soliciting materials. T
• 8-K Filing — 8-K · Dec 31, 2025
• 8-K Filing — 8-K · Dec 18, 2025
• 8-K Filing — 8-K · Dec 8, 2025
• 8-K Filing — 8-K · Dec 2, 2025
• Owens & Minor's Q3 Net Loss Widens to $150M Amid P&HS Divestiture — 10-Q · Oct 31, 2025 Risk: high
  Owens & Minor Inc. reported a significant net loss of $150.276 million for the three months ended September 30, 2025, a substantial increase from the $12.770 mi
• Owens & Minor Files 8-K on Financials — 8-K · Oct 30, 2025 Risk: low
  Owens & Minor, Inc. (OMI) filed an 8-K on October 30, 2025, reporting on its results of operations and financial condition. The filing also includes information
• Owens & Minor Files 8-K for Material Agreement — 8-K · Oct 7, 2025 Risk: medium
  On October 7, 2025, Owens & Minor, Inc. (NYSE: OMI) filed an 8-K to report the entry into a material definitive agreement. The filing also includes Regulation F
• Owens & Minor Announces Board and Executive Changes — 8-K · Sep 19, 2025 Risk: medium
  Owens & Minor, Inc. announced on September 15, 2025, changes in its board of directors and executive compensation. The filing details the departure of certain o
• Owens & Minor Q2 Net Income Jumps 18% on Strong Revenue Growth — 10-Q · Aug 11, 2025 Risk: medium
  Owens & Minor Inc. reported a net income of $50.1 million for the three months ended June 30, 2025, a significant increase from $42.5 million in the prior-year
• Owens & Minor Files 8-K on Operations — 8-K · Aug 11, 2025 Risk: low
  Owens & Minor, Inc. filed an 8-K on August 11, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disc
• Owens & Minor 8-K: Financial Obligation Trigger — 8-K · Jun 6, 2025 Risk: medium
  On June 5, 2025, Owens & Minor, Inc. (NYSE: OMI) filed an 8-K to disclose a triggering event that accelerates or increases a direct financial obligation. This r
• Owens & Minor Enters and Terminates Agreements — 8-K · Jun 5, 2025 Risk: medium
  On June 5, 2025, Owens & Minor, Inc. entered into a Material Definitive Agreement and also terminated a Material Definitive Agreement. The specific details of t
• Owens & Minor Reports on Shareholder Votes — 8-K · May 16, 2025 Risk: low
  Owens & Minor, Inc. (OMI) filed an 8-K on May 15, 2025, to report on matters submitted to a vote of its security holders. The filing does not disclose specific
• Owens & Minor Files Q1 2025 10-Q — 10-Q · May 8, 2025 Risk: low
  Owens & Minor, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter
• Owens & Minor Enters Material Definitive Agreement — 8-K · Apr 4, 2025 Risk: medium
  On April 4, 2025, Owens & Minor, Inc. entered into a material definitive agreement related to a direct financial obligation. The company, headquartered in Glen
• Owens & Minor Files 8-K — 8-K · Apr 2, 2025 Risk: low
  Owens & Minor, Inc. filed an 8-K on April 2, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain speci
• Owens & Minor Files 8-K — 8-K · Mar 26, 2025 Risk: low
  Owens & Minor, Inc. (OMI) filed an 8-K on March 26, 2025, reporting on other events and financial statements. The filing does not contain specific financial fig
• Owens & Minor Files 8-K for Reg FD and Exhibits — 8-K · Mar 20, 2025 Risk: low
  Owens & Minor, Inc. filed an 8-K on March 20, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain spec
• Owens & Minor Files 2024 10-K — 10-K · Feb 28, 2025 Risk: medium
  Owens & Minor, Inc. filed its 2024 10-K on February 28, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The filing detai
• Owens & Minor Files 8-K on Financials — 8-K · Feb 3, 2025 Risk: low
  On February 3, 2025, Owens & Minor, Inc. filed an 8-K report detailing results of operations, financial condition, and Regulation FD disclosures. The filing inc
• SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Owens & Minor Announces Executive and Director Changes — 8-K · Nov 5, 2024 Risk: medium
  Owens & Minor, Inc. announced on October 30, 2024, changes in its executive and director leadership. The company elected new directors and appointed new officer
• Owens & Minor Q3 2024: $7.2B in Sales — 10-Q · Nov 4, 2024 Risk: medium
  Owens & Minor Inc. reported its Q3 2024 results, with net sales for the nine months ending September 30, 2024, reaching $7.2 billion. The company's financial st
• Owens & Minor Enters Material Definitive Agreement — 8-K · Oct 22, 2024 Risk: medium
  On October 18, 2024, Owens & Minor, Inc. entered into a material definitive agreement related to a direct financial obligation. The company, incorporated in Vir
• Owens & Minor Sells Medical Distribution to Cardinal Health for $1B — 8-K · Oct 15, 2024 Risk: medium
  Owens & Minor, Inc. announced on October 11, 2024, that it has entered into a definitive agreement to sell its Medical Distribution business to an affiliate of
• Owens & Minor Names New CFO, Sets Compensation — 8-K · Sep 23, 2024 Risk: medium
  Owens & Minor, Inc. announced on September 23, 2024, changes in its executive compensation arrangements. Specifically, the company entered into an employment ag
• Owens & Minor Sells Medical Distribution to Cardinal Health for $1B — 8-K · Sep 16, 2024 Risk: medium
  Owens & Minor, Inc. announced on September 16, 2024, that it has entered into a definitive agreement to sell its Medical Distribution business to Cardinal Healt
• Owens & Minor Files 8-K on Financials — 8-K · Aug 2, 2024 Risk: low
  Owens & Minor, Inc. (NYSE: OMI) filed an 8-K on August 2, 2024, reporting on its results of operations and financial condition. The filing also includes Regulat
• Owens & Minor Files 8-K for Regulation FD Disclosure — 8-K · Jul 31, 2024 Risk: low
  On July 31, 2024, Owens & Minor, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure, indicating a public announcement or disclos
• Owens & Minor Enters Material Definitive Agreement — 8-K · Jul 23, 2024 Risk: medium
  Owens & Minor, Inc. announced on July 22, 2024, that it has entered into a Material Definitive Agreement. The company also disclosed information related to Regu
• Owens & Minor Appoints New CFO, Ruiz — 8-K · Jun 24, 2024 Risk: medium
  Owens & Minor, Inc. announced on June 21, 2024, the appointment of Ms. Pamela G. Ruiz as the new Executive Vice President and Chief Financial Officer, effective
• Owens & Minor CFO Departs; New Directors Elected — 8-K · May 24, 2024 Risk: medium
  Owens & Minor, Inc. announced on May 24, 2024, the departure of its Chief Financial Officer, Richard L. Allen, effective immediately. The company has appointed
• Owens & Minor Appoints New Directors, Adjusts Executive Pay — 8-K · May 10, 2024 Risk: low
  Owens & Minor, Inc. announced on May 9, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new directors,
• Owens & Minor Appoints Karen L. LeFrak to Board — 8-K · May 9, 2024 Risk: low
  Owens & Minor, Inc. announced on May 9, 2024, the appointment of Ms. Karen L. LeFrak as a new Class III director to its Board of Directors, effective immediatel
• Owens & Minor Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 3, 2024 Risk: medium
  OWENS & MINOR INC/VA/ (ACH) filed a Quarterly Report (10-Q) with the SEC on May 3, 2024. Owens & Minor Inc. filed a 10-Q report for the period ending March 31,
• Owens & Minor Appoints New CFO, Andrew Wilson — 8-K · Apr 22, 2024 Risk: medium
  Owens & Minor, Inc. announced on April 16, 2024, the appointment of Andrew R. Wilson as the new Executive Vice President and Chief Financial Officer, effective
• Owens & Minor Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Mar 27, 2024 Risk: low
  OWENS & MINOR INC/VA/ (ACH) filed a Proxy Statement (DEF 14A) with the SEC on March 27, 2024. Owens & Minor Inc. filed a Definitive Proxy Statement (DEF 14A) on
• Owens & Minor Appoints New CFO — 8-K · Mar 1, 2024 Risk: medium
  Owens & Minor, Inc. announced on February 28, 2024, the appointment of Ms. Brenda J. Johnson as the new Executive Vice President and Chief Financial Officer, ef
• Owens & Minor Files 8-K on Financial Results and Disclosure — 8-K · Feb 20, 2024 Risk: low
  Owens & Minor, Inc. filed an 8-K on February 20, 2024, reporting on its results of operations and financial condition, as well as Regulation FD Disclosure. The
• Vanguard Amends Owens & Minor Stake to 13.9% as of Dec 29 — SC 13G/A · Feb 13, 2024 Risk: low
  The Vanguard Group, a major investment firm, filed an amended Schedule 13G/A on February 13, 2024, updating its ownership in Owens & Minor Inc. As of December 2
• Deerfield Mgmt Amends 13G/A on Owens & Minor Stake — SC 13G/A · Feb 12, 2024 Risk: low
  Deerfield Mgmt, L.P. filed an amended SC 13G/A on February 12, 2024, indicating a change in their beneficial ownership of Owens & Minor, Inc. (OM) common stock
• Dimensional Fund Advisors Reports 7.70% Stake in Owens & Minor — SC 13G · Feb 9, 2024 Risk: low
  Dimensional Fund Advisors LP, a major investment firm, reported on February 9, 2024, that it holds a significant stake in Owens & Minor Inc. (NYSE: OMI). As of
• FMR LLC & Abigail Johnson Hold 13.635% Stake in Owens & Minor — SC 13G/A · Feb 9, 2024 Risk: low
  FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Owens & Minor Inc./VA/. As of December 31,
• BlackRock Amends Owens & Minor Stake, Signals Passive Investment — SC 13G/A · Jan 22, 2024
  BlackRock Inc. filed an amended Schedule 13G/A on January 22, 2024, indicating its ownership of Owens & Minor Inc. common stock as of December 31, 2023. This am

Risk Profile

Risk Assessment: Of ACH's 40 recent filings, 1 were flagged as high-risk, 19 as medium-risk, and 20 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Accendra Health INC/Va/'s most recent 10-Q filing (Oct 31, 2025):

• Revenue: $2,053,065,000
• Net Income: -$1,044,316,000
• EPS: -$13.55
• Debt-to-Equity: N/A
• Cash Position: N/A
• Operating Margin: 0.3%
• Total Assets: N/A
• Total Debt: N/A

Key Executives

• Richard L. Allen
• Pamela G. Ruiz
• Jeremy L. Warren
• Christopher J. Lowery
• Robert J. Miller
• David M. Smith
• Richard J. Allen
• Karen L. LeFrak
• Andrew R. Wilson
• Brenda J. Johnson
• Flynn James E
• December 29, 2023
• February 9, 2024
• Abigail P. Johnson

Industry Context

Owens & Minor operates in the highly competitive healthcare distribution and medical products manufacturing sectors. The industry is characterized by consolidation, increasing demand for efficiency, and evolving regulatory landscapes. Companies like Owens & Minor face pressure to manage complex supply chains, integrate acquisitions, and adapt to shifts in healthcare delivery models.

Top Tags

regulation-fd (5) · institutional-ownership (5) · material-agreement (4) · executive-appointment (4) · cfo (4) · amendment (4) · executive-compensation (3) · 8-K (3) · 10-Q (3) · financials (3)

Key Numbers

• Net loss for nine months ended Sept 30, 2025: $1.044B — Significantly increased from $66.570 million in 2024, primarily due to discontinued operations.
• Loss from discontinued operations, net of tax, for nine months ended Sept 30, 2025: $951.077M — Major driver of the overall net loss, reflecting the P&HS segment divestiture.
• Loss on classification to held for sale: $771.640M — A significant non-cash charge related to the P&HS segment.
• Cash sale price for P&HS segment: $375M — Expected proceeds from the divestiture, subject to adjustments.
• Net revenue for three months ended Sept 30, 2025: $697.264M — Modest increase from $686.846 million in the prior year quarter.
• Operating income for nine months ended Sept 30, 2025: $6.551M — Sharp decline from $54.969 million in 2024, impacted by fees and charges.
• Total (deficit) equity as of Sept 30, 2025: $(429.507)M — A significant negative shift from $586.364 million positive equity at Dec 31, 2024.
• Transaction breakage fee: $80M — Incurred during the nine months ended September 30, 2025, impacting operating costs.
• Net Income Q2 2025: $50.1M — Increased by 18% from $42.5M in Q2 2024
• Revenue Q2 2025: $2.6B — Increased by 4% from $2.5B in Q2 2024
• Net Income Growth: 18% — Year-over-year increase from Q2 2024 to Q2 2025
• Revenue Growth: 4% — Year-over-year increase from Q2 2024 to Q2 2025
• Operating Income Q2 2025: $85.3M — Represents a 15% improvement year-over-year
• Retained Earnings: $1.5B — As of June 30, 2025, indicating strong financial stability
• Accumulated Other Comprehensive Income: -$120.5M — As of June 30, 2025, primarily due to translation adjustments

Forward-Looking Statements

• {"claim":"Vanguard will likely maintain a significant, passive stake in Owens & Minor for the foreseeable future.","entity":"The Vanguard Group","targetDate":"December 29, 2024","confidence":"high"}
• {"claim":"Other institutional investors may increase their positions in Owens & Minor Inc. following Dimensional Fund Advisors LP's significant stake disclosure.","entity":"Owens & Minor Inc.","targetDate":"Next 6-12 months","confidence":"medium"}
• {"claim":"FMR LLC will maintain a significant, passive stake in Owens & Minor Inc. for the foreseeable future.","entity":"FMR LLC","targetDate":"2025-02-09","confidence":"high"}

Related Companies

OMI · MCK · CAH · ABC · OWNS · OWM · OM

Frequently Asked Questions